Work

Long‐term safety and tolerability of zavegepant 10‐mg nasal spray with concomitant use of anti‐calcitonin gene‐related peptide monoclonal antibodies or other select preventive migraine medications: Results from a phase 2/3 open‐label study

Year: 2025

Type: article

Source: Headache The Journal of Head and Face Pain

DOI: 10.1111/head.14954

Authors: Gary Berman, Kathleen Mullin, Timothy Smith, Linda Mosher, Samantha Sweeney, Robert J. Fountaine

Institutions: Clinical Research Institute, New England Institute for Neurology and Headache, Pfizer (United States)

Language: English

Topic: Migraine and Headache Studies

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Biohaven Pharmaceuticals

OpenAlex ID: W4410548749

FWCI: 2.47

Cites: 33

Cited by: 4

Related to: 10